food and drug administration]
Latest from food and drug administration
- The meeting would have evaluated whether two doses of the Covid-19 vaccine shot should be authorised for children aged six months through four years, even though clinical trials are still evaluating whether three shots are needed.
The FDA said it reviewed published data and real world evidence on the safety of booster doses provided by the Israeli Ministry of Health including data from over 6,300 individuals 12-to-15 years of age who received a Pfizer shot.
The FDA warned the drug Evusheld is “not a substitute for vaccination in individuals for whom Covid-19 vaccination is recommended” and can only be authorized for people who have a weakened immune system or those who cannot be vaccinated for medical reasons, such as a strong allergic reaction.
According to the CDC, more than a third of fully vaccinated senior citizens in the US had already received their booster doses as of Thursday, and 17 per cent of fully vaccinated adults overall have had an additional shot of vaccine.
Written by Joydeep Bose | Edited by Poulomi Ghosh, Hindustan Times, New Delhi
The decision from the FDA will likely come before a US Centers for Disease Control and Prevention (CDC) advisory panel meets on Friday to discuss expanding the eligibility for booster doses of Pfizer/BioNTech's vaccine, currently allowed for select groups of people.